ACH Accendra Health, Inc. Common Stock
NYSE · Health Care · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ene 24, 2024ACH Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
ACH Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 1 de abril de 2010 | 3-for-2 | Adelante |
| 9 de junio de 1994 | 3-for-2 | Adelante |
| 23 de marzo de 1993 | 3-for-2 | Adelante |
| 17 de julio de 1991 | 3-for-2 | Adelante |
| 1 de junio de 1988 | 3-for-2 | Adelante |
| 3 de septiembre de 1985 | 3-for-2 | Adelante |
| 1 de noviembre de 1982 | 2-for-1 | Adelante |
Acerca de Accendra Health, Inc. Common Stock Descripción general de la empresa de Wikipedia
Accendra Health is a global healthcare company. It employs over 20,000 people in 70 countries. A Fortune 500 company, it was founded in 1882 in Richmond, Virginia, where it remains headquartered. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. President and CEO Ed Pesicka joined Owens & Minor in March 2019.
History
Owens & Minor originally opened as a pharmacy company in downtown Richmond, Virginia in 1882, inside a historic building which still stands today. The company continued this business for over half a century until, in 1954, Gil Minor, Jr. bought out Bodeker Drug Company, a smaller operation in the same industry, changing the company name to Owens, Minor & Bodeker.
In 1966, the company acquired Virginia A&J Hospital Supply, adding medical and surgical distribution to its portfolio. By 1970, OMB had opened Cardinal Drug Centers, merchandising its products to independent drug companies, stocking shops with over 25,000 items within two years. Around this time, disposable items were distributed to hospitals for various medical procedures. G. Gilmer Minor III, a direct relation to the founder, became CEO in 1984. By 1988, Owens & Minor began trading on the New York Stock Exchange under the ticker OMI. It was around this time that revenues earned the company a Fortune 500 ranking.
By 1999, the company had refocused toward medical supply chain management. Throughout the 2000s, Owens & Minor acquired various medical distributors across the United States, notably the hospital distributor McKesson Medical-Surgical Inc., a business unit of McKesson, for $152.1 million, on September 30, 2006. In 2012, it entered the European market, opening offices in Spain, France, Germany, Poland, and the Czech Republic after the acquisition of Movianto Group. In 2014, the corporation acquired ArcRoyal, a privately held medical kit company based in Dublin, Ireland.
In 2018, it acquired Halyard Health’s Surgical & Infection Prevention business for $710 million, the largest acquisition in the company’s history. Halyard is a manufacturer of sterilization wrap, facial protection products, exam gloves, protective apparel, surgical drapes and surgical gowns.
In May 2022, Owens & Minor stated that 45 percent of the items it offers are in some way supply-constrained due to the 2021–2022 global supply chain crisis. The following month, the company broke ground in Morgantown, West Virginia for a 350,000 square-foot medical supplies and logistics center, to be completed in late 2023, which will include dedicated acute care medical distribution facilities and clinical supply capabilities.
In July 2024, the company announced it had agreed to acquire medical equipment firm Rotech Healthcare for $1.36 billion. However, the companies terminated the deal in June 2025, citing regulatory hurtles. As a result, the Owens & Minor paid Rotech an $80 million termination payment.
Personnel
On March 7, 2019 Edward A. Pesicka became president and CEO, then also joined the company's Board of Directors. Pesicka was a former executive at Thermo Fisher Scientific.
Richmond, Virginia center
In the fourth quarter of 2017, Owens & Minor opened a second office and customer service center in downtown Richmond, Virginia as part of a business rebranding strategy. The corporation also continued to work from its various offices across the United States.
Movianto
In 2018, the company’s Movianto subsidiary won a contract estimated at £10.5m a year to warehouse and distribute the UK government’s stock of emergency personal protection equipment (PPE) which had previously been managed by DHL.
Following a dispute over payment of rent, Movianto gained a UK High Court injunction in March 2019 to stop Industrial North West LLP, owner of the rented industrial property, from locking the gates and thereby preventing the company from conducting its business.
In 2020, Movianto was criticised as causing delays to the distribution of the UK government’s stockpile of PPE. Following news of shortages in hospitals, the British army was sent to Movianto’s warehouse to assist in the rapid deployment of PPE, with the Department of Health and Social Care contradicting the allegation. An investigation did establish, however, that Movianto had previously stored the equipment in a smoke-damaged warehouse that was found to contain asbestos.
On January 16, 2020, Owens & Minor announced its intention to sell its European logistics business, Movianto, to EHDH Holding Group (EHDH), a privately held French company providing healthcare logistics services to European markets, with the sale completed June 18, 2020.
Divest of P&HS - Rebrand Accendra Health, Inc.
On December 31 2025, Owens & Minor, Inc. announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc.
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Aún no hay datos fundamentales para este ticker.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Aún no hay datos fundamentales para este ticker.
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Aún no hay datos fundamentales para este ticker.
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
| Fecha ex-dividendo | Monto | Moneda | Rendimiento |
|---|---|---|---|
| Dic 14, 2021 | $0,00 | USD | ≈0.03% |
| Sep 14, 2021 | $0,00 | USD | ≈0.03% |
| Jun 14, 2021 | $0,00 | USD | ≈0.03% |
| Mar 12, 2021 | $0,00 | USD | ≈0.03% |
| Dic 14, 2020 | $0,00 | USD | ≈0.04% |
| Sep 14, 2020 | $0,00 | USD | ≈0.08% |
| Jun 12, 2020 | $0,00 | USD | ≈0.16% |
| Mar 13, 2020 | $0,00 | USD | ≈0.28% |
| Dic 13, 2019 | $0,00 | USD | ≈1.6% |
| Sep 13, 2019 | $0,00 | USD | ≈5.5% |
| Jun 13, 2019 | $0,00 | USD | ≈20.8% |
| Mar 14, 2019 | $0,00 | USD | ≈12.6% |
| Dic 14, 2018 | $0,08 | USD | ≈13.2% |
| Sep 14, 2018 | $0,26 | USD | ≈6.4% |
| Jun 14, 2018 | $0,26 | USD | ≈6.4% |
| Mar 14, 2018 | $0,26 | USD | ≈6.2% |
| Dic 14, 2017 | $0,26 | USD | ≈5.5% |
| Sep 14, 2017 | $0,26 | USD | ≈3.6% |
| Jun 13, 2017 | $0,26 | USD | ≈3.2% |
| Mar 13, 2017 | $0,26 | USD | ≈2.9% |
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 10, 2026 | $-0.19 | $-0.09 | -113.0% |
| 31 de marzo de 2026 | $-0.04 | $-0.10 | 60.9% | |
| 31 de diciembre de 2025 | $0.21 | $0.22 | -5.8% | |
| 30 de septiembre de 2025 | $0.25 | $0.23 | 6.7% | |
| 30 de junio de 2025 | $0.26 | $0.28 | -6.3% | |
| 31 de marzo de 2025 | $0.23 | $0.20 | 16.6% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $290.99B | $298.89B | $203.99B | $190.22B | $180.35B | $181.02B | $144.85B | |
| Cost of Revenue | $259.70B | $264.17B | $188.52B | $179.28B | $167.11B | $166.29B | $133.70B | |
| Gross Profit | $31.28B | $34.72B | $15.47B | $10.93B | $13.24B | $14.73B | $11.15B | |
| R&D Expense | $4.81B | $2.42B | $1.47B | $941M | $627M | $498M | $169M | |
| SG&A Expense | $6.01B | $6.33B | $5.06B | $3.97B | $3.98B | $4.55B | · | |
| Operating Income | $16.39B | $18.67B | $7.60B | $6.21B | $6.82B | · | · | |
| Interest Expense | $3.83B | $4.51B | $4.99B | $4.38B | $4.69B | $4.83B | $4.76B | |
| Interest Income | $477M | $311M | $266M | $261M | $492M | $707M | $816M | |
| Pretax Income | $13.21B | $14.19B | $2.89B | $1.87B | $2.27B | $3.05B | $1.62B | |
| Income Tax | $2.37B | $2.87B | $641M | $632M | $826M | $644M | $404M | |
| Net Income | $4.19B | $5.76B | $862M | $596M | $709M | $1.41B | $366M | |
| EPS (Basic) | $0.24 | $0.33 | $0.03 | $0.02 | $0.03 | $0.09 | $0.02 | |
| EPS (Diluted) | $0.24 | $0.33 | $0.03 | $0.02 | · | · | · | |
| Shares (Basic) | 17,022,673 | 17,022,673 | 17,022,673 | 17,022,673 | 16,842,714 | 14,903,798,236 | 14,903,798,236 | |
| Shares (Diluted) | · | · | · | 17,022,672,951 | 16,842,713,738 | 14,903,798,236 | 14,903,798,236 | |
| EBITDA | $16.39B | $13.41B | $6.02B | · | · | · | · |
Balance general
| Métrica | Tendencia | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16.82B | $19.68B | $9.67B | $7.78B | $19.13B | $27.85B | $23.85B | |
| Receivables | $5.87B | $7.11B | $9.31B | $7.42B | $8.10B | · | · | |
| Inventory | $24.71B | $21.64B | $19.86B | $19.52B | $20.46B | $20.55B | $17.93B | |
| Current Assets | $54.54B | $54.11B | $46.27B | $48.70B | $58.90B | $68.64B | $66.49B | |
| PP&E (Net) | $109.28B | $121.38B | $130.93B | $103.49B | $99.61B | $95.73B | $90.37B | |
| Goodwill | $3.50B | $3.51B | $3.51B | · | · | · | · | |
| Total Assets | $212.35B | $224.86B | $195.04B | $203.14B | $200.96B | $199.82B | $190.51B | |
| Current Liabilities | $62.37B | $61.92B | $62.63B | $69.20B | $74.84B | $90.34B | $83.18B | |
| Total Liabilities | $124.59B | $135.17B | $123.74B | $132.38B | $133.30B | $134.07B | $134.72B | |
| Retained Earnings | $10.09B | $6.81B | $-1.98B | $-2.21B | $-2.86B | $-3.33B | $-4.64B | |
| Stockholders' Equity | $54.40B | $60.48B | $54.45B | $54.67B | $52.42B | $39.69B | $38.17B |
Flujo de Efectivo
| Métrica | Tendencia | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $8.06B | $7.06B | $7.00B | |
| Operating Cash Flow | $27.75B | $35.16B | $19.42B | $12.51B | $13.02B | $13.21B | $11.61B | |
| CapEx | $4.42B | $3.19B | $10.33B | $9.05B | $6.75B | $8.89B | $6.33B | |
| Investing Cash Flow | $-3.42B | $-1.67B | $-3.31B | $-13.40B | $-5.53B | $-5.60B | $-2.63B | |
| Dividends Paid | $2.51B | $579M | $423M | $223M | $328M | $309M | $20M | |
| Financing Cash Flow | $-27.04B | $-23.41B | $-18.23B | $-10.47B | $-16.28B | $-3.39B | $-6.11B | |
| Free Cash Flow | $23.33B | $26.19B | $9.84B | $3.58B | · | · | · | |
| Levered FCF | $20.19B | $23.50B | $7.02B | $501M | · | · | · |
Rentabilidad
| Métrica | Tendencia | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 10.8% | 9.8% | 7.2% | 6.4% | · | · | · | |
| Operating Margin | 5.6% | 5.0% | 3.2% | · | · | · | · | |
| Net Margin | 1.4% | 1.9% | 0.40% | 0.45% | · | · | · | |
| Pretax Margin | 4.5% | 3.8% | 1.2% | 1.1% | · | · | · | |
| EBITDA Margin | 5.6% | 5.0% | 3.2% | · | · | · | · | |
| ROA | 1.9% | 2.6% | 0.37% | 0.42% | · | · | · | |
| ROE | 7.3% | 9.1% | 1.4% | 1.6% | · | · | · | |
| ROIC | 24.7% | 17.9% | 8.1% | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.7 | 0.7 | · | · | · | |
| Quick Ratio | 0.4 | 0.5 | 0.3 | 0.2 | · | · | · | |
| Interest Coverage | 4.3 | 3.8 | 1.6 | · | · | · | · |
Eficiencia
| Métrica | Tendencia | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.4 | 0.9 | 0.9 | · | · | · | |
| Inventory Turnover | 11.2 | 12.6 | 8.8 | 8.9 | · | · | · | |
| Receivables Turnover | 44.8 | 33.3 | 22.3 | 24.5 | · | · | · |
Por Acción
| Métrica | Tendencia | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | · | · | · | $11.17 | · | · | · | |
| Cash Flow / Share | · | · | · | $0.73 | · | · | · | |
| EPS (TTM) | $0.24 | $0.29 | $0.03 | $0.02 | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $290.99B | $269.75B | $185.99B | $190.22B | · | · | · | |
| Net Income TTM | $4.19B | $5.08B | $764M | $596M | · | · | · | |
| P/E | 81.7 | 152.1 | 901.7 | 235.0 | · | · | · | |
| Earnings Yield | 1.2% | 0.66% | 0.11% | 0.43% | · | · | · | |
| Payout Ratio | 60.0% | 9.1% | 48.1% | 26.2% | · | · | · | |
| Annual Payout | $2.51B | $461M | $356M | $223M | · | · | · |
Por Acción
| Métrica | Tendencia | Q4 2022 | Q4 2021 | Q4 2019 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | · | $0.29 | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q4 2022 | Q4 2021 | Q4 2019 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $269.75B | · | · | $144.85B | $123.67B | · | · | · | · | · | |
| Net Income TTM | · | $5.08B | · | · | $366M | $130M | · | · | · | · | · | |
| P/E | · | 152.1 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | 0.66% | · | · | · | · | · | · | · | · | · | |
| Annual Payout | · | $461M | · | · | $20M | $20M | · | · | · | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Ingresos | $290.99B | $298.89B | $203.99B | $190.22B | $180.35B |
| Margen Bruto % | 10.8% | 9.8% | 7.2% | 6.4% | · |
| Margen Operativo % | 5.6% | 5.0% | 3.2% | · | · |
| Beneficio neto | $4.19B | $5.76B | $862M | $596M | $709M |
| EPS Diluido | $0.24 | $0.33 | $0.03 | $0.02 | · |
| Métrica | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 0.9 | 0.9 | 0.7 | 0.7 | · |
| Ratio Rápido | 0.4 | 0.5 | 0.3 | 0.2 | · |
| Métrica | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $23.33B | $26.19B | $9.84B | $3.58B | · |
Propietarios institucionales (13F) 161 declarantes · $236.6M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 22 (-7 vs trimestre anterior) | 21 (-25 vs trimestre anterior) | 47 (+8 vs trimestre anterior) | 45 (-7 vs trimestre anterior) | -61K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Coliseum Capital Management, LLC | $44 804 760 | 13 100 807 | 18,94% | Acciones |
| BlackRock, Inc. | $18 824 028 | 5 504 102 | 7,96% | Acciones |
| VANGUARD GROUP INC | $17 691 199 | 6 318 285 | 7,48% | Acciones |
| BANK OF AMERICA CORP /DE/ | $12 912 296 | 3 775 525 | 5,46% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $10 560 724 | 3 087 931 | 4,46% | Acciones |
| D. E. Shaw & Co., Inc. | $10 538 412 | 3 081 407 | 4,45% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9 877 158 | 2 888 058 | 4,17% | Acciones |
| Invenomic Capital Management LP | $9 618 661 | 2 812 474 | 4,07% | Acciones |
| MARSHALL WACE, LLP | $8 832 423 | 2 582 579 | 3,73% | Acciones |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $8 675 511 | 2 536 699 | 3,67% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6 945 870 | 2 030 956 | 2,94% | Acciones |
| Dana Investment Advisors, Inc. | $6 650 556 | 1 944 607 | 2,81% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $6 408 062 | 1 873 127 | 2,71% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $5 609 358 | 1 640 163 | 2,37% | Acciones |
| STATE STREET CORP | $5 475 974 | 1 601 162 | 2,31% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $4 407 652 | 1 288 787 | 1,86% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $3 650 249 | 1 067 324 | 1,54% | Acciones |
| GOLDMAN SACHS GROUP INC | $2 923 176 | 854 730 | 1,24% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $2 457 441 | 718 550 | 1,04% | Acciones |
| NORTHERN TRUST CORP | $1 989 770 | 581 804 | 0,84% | Acciones |
| WOLVERINE ASSET MANAGEMENT LLC | $1 942 847 | 568 084 | 0,82% | Acciones |
| TUDOR INVESTMENT CORP ET AL | $1 939 995 | 567 250 | 0,82% | Acciones |
| JANE STREET GROUP, LLC | $1 833 462 | 536 100 | 0,77% | Opción de compra |
| Vanguard Global Advisers, LLC | $1 742 463 | 509 492 | 0,74% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 665 913 | 487 109 | 0,70% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 575 252 | 460 600 | 0,67% | Opción de compra |
| TWO SIGMA ADVISERS, LP | $1 518 922 | 542 472 | 0,64% | Acciones |
| BW Gestao de Investimentos Ltda. | $1 446 971 | 423 091 | 0,61% | Acciones |
| CITADEL ADVISORS LLC | $1 321 919 | 386 526 | 0,56% | Acciones |
| CITADEL ADVISORS LLC | $1 191 528 | 348 400 | 0,50% | Opción de compra |
| Nebula Research & Development LLC | $1 115 105 | 122 539 | 0,47% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 109 492 | 324 413 | 0,47% | Acciones |
| MORGAN STANLEY | $1 052 342 | 307 701 | 0,44% | Acciones |
| Linden Thomas Advisory Services, LLC | $932 501 | 272 661 | 0,39% | Acciones |
| Bank of New York Mellon Corp | $917 257 | 268 204 | 0,39% | Acciones |
| Nuveen, LLC | $803 515 | 234 946 | 0,34% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $794 692 | 232 366 | 0,34% | Acciones |
| Kennondale Capital Management LLC | $772 544 | 225 890 | 0,33% | Acciones |
| STRS OHIO | $716 148 | 209 400 | 0,30% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $690 902 | 202 018 | 0,29% | Acciones |
| Cubist Systematic Strategies, LLC | $593 424 | 123 630 | 0,25% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $546 095 | 159 677 | 0,23% | Acciones |
| WELLS FARGO & COMPANY/MN | $542 754 | 158 700 | 0,23% | Acciones |
| XTX Topco Ltd | $503 725 | 147 288 | 0,21% | Acciones |
| ARISTEIA CAPITAL, L.L.C. | $447 391 | 130 816 | 0,19% | Acciones |
| Invesco Ltd. | $446 351 | 130 512 | 0,19% | Acciones |
| Man Group plc | $436 009 | 127 488 | 0,18% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $408 047 | 119 312 | 0,17% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $362 520 | 106 000 | 0,15% | Acciones |
| Allspring Global Investments Holdings, LLC | $356 879 | 99 687 | 0,15% | Acciones |
Propiedad de ETFs Mantenido por 18 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| VFVA · VANGUARD WELLINGTON FUND | 0,17% | 426 785 SH | 19 de agosto de 2026 | Diario |
| QIDX · Spinnaker ETF Series | 0,11% | 14 310 NS | 31 de julio de 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 62 833 SH | 19 de agosto de 2026 | Diario |
| IWC · iShares Trust | 0,02% | 248 081 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 414 904 SH | 19 de agosto de 2026 | Diario |
| DFSV · Dimensional ETF Trust | 0,01% | 233 042 NS | 31 de julio de 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 34 414 NS | 31 de julio de 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,00% | 134 690 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 1 902 936 SH | 11 de septiembre de 2026 | Diario |
| PRF · Invesco Exchange-Traded Fund Trust | 0,00% | 96 796 SH | 1 de octubre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 29 296 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 105 616 SH | 8 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 19 827 SH | 3 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 833 270 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 185 973 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6 453 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,00% | 184 892 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 666 394 SH | 11 de septiembre de 2026 | Diario |
ACH Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
Precio objetivo a 12 meses
4 analistas · 2026-09-30Objetivo medio $1.51 +199,4%
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.